News

“Liberation Day”– Trump Announces Reciprocal Tariffs, Ends De Minimis Treatment for China

By EsqSocial Corporation 03/04/25

On April 2, President Donald Trump issued a series of executive orders (EOs) to impose reciprocal tariffs on select countries and revoke China’s eligibility for the de minimis exemption. The long-previewed actions fulfill a key campaign promise and build on the president’s efforts to reform U.S.

Whistle While You Work: Pursuing passions that elevate your legal career

By EsqSocial Corporation 03/04/25

Bloomberg Government Interviews Sam Finnerty on Trump’s Overhaul of Federal Contracting and GSA’s Pivotal Role

By EsqSocial Corporation 03/04/25

In a March 20 executive order, President Trump directed federal agencies to submit plans to consolidate procurement for “common goods and services” under the General Services Administration, which puts the agency in charge of contracts in 10 broad market categories that were worth $495 Billion in

Divorce Dramatics: Dial it Down

By EsqSocial Corporation 03/04/25

Many clients dream of a low-conflict divorce. And for good reason—a peaceful separation benefits everyone involved: the spouses, the children, and even their finances. But what happens when one spouse uses the divorce process as an opportunity to provoke the other?...

MintzTech Connect: All Things Technology — April 2025

By EsqSocial Corporation 03/04/25

Challenging times. The stock market is choppy, and uncertainty about the economy and politics is pervasive. That said, we have seen that venture capitalists with conviction are making big bets.

Delaware Enacts Sweeping Changes to the Delaware General Corporation Law

By EsqSocial Corporation 03/04/25

The Delaware Legislature passed, and Delaware Gov. Matt Meyer signed on March 25, 2025, the landmark Senate Bill 21. Senate Bill 21 amends the Delaware General Corporation Law (the "DGCL") in significant ways, with broad ramifications for controller transactions and related litigation....

The Crucial Role of Patent Due Diligence in Mergers & Acquisitions: Spotting Patent Litigation Risks Before Closing a Deal

By EsqSocial Corporation 03/04/25

In today’s rapidly evolving business landscape, mergers and acquisitions (“M&A”) remain a common strategic priority for companies aiming to grow, innovate, or strengthen their market position.

FDA Finds Significant Bioequivalence Concerns in Raptim Studies Leading to ANDA and NDA Reviews

By EsqSocial Corporation 03/04/25

In a highly unusual move, on March 27, the US Food and Drug Association (FDA) issued a Drug Safety Notice that calls into question both pending and approved abbreviated new drug applications (ANDAs) and new drug applications (NDAs) that relied on bioequivalence studies conducted by Raptim Researc

Federal Judge Restrains Liability for Alleged False DEI Certifications

By EsqSocial Corporation 03/04/25

President Trump’s January 21 Executive Order targeting Diversity, Equity, and Inclusion Programs (DEI) (the “January 21 Executive Order”) and, specifically, § 3(b)(iv)) (the Certification Provision) cannot be the basis for liability — at least for one proactive litigant in the Northern District o

SEC Provides Further Clarity in Rule 506(c) Offerings

By EsqSocial Corporation 03/04/25

On March 12, 2025, the Securities and Exchange Commission (the “SEC”) issued a No-Action Letter that provided guidance regarding the ways issuers can satisfy the accredited investor verification requirements of offerings made pursuant to Rule 506(c) under Regulation D.

Pages